Marinella Clerico Selected Research

Marinella Clerico Research Topics

Disease

35	Multiple Sclerosis 03/2024 - 07/2004
11	Relapsing-Remitting Multiple Sclerosis 01/2020 - 07/2004
6	COVID-19 01/2023 - 01/2021
4	Progressive Multifocal Leukoencephalopathy 05/2021 - 08/2014
3	Infections 01/2023 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 10/2014
2	Breakthrough Infections 01/2023 - 11/2022
2	Lymphopenia (Lymphocytopenia) 01/2022 - 12/2017
2	Disease Progression 01/2022 - 01/2018
2	Sudden Infant Death (SID) 05/2021 - 01/2020
2	Sialorrhea 11/2016 - 12/2015
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 11/2023
1	Polyneuropathies (Polyneuropathy) 11/2023
1	Pneumonia (Pneumonitis) 12/2022
1	Myasthenia Gravis 12/2021
1	Stroke (Strokes) 03/2021
1	Inflammation (Inflammations) 02/2016
1	Nervous System Diseases (Neurological Disorders) 12/2015
1	Deglutition Disorders (Dysphagia) 12/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2014
1	Friedreich Ataxia (Friedreich's Ataxia) 10/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2014
1	Thymoma (Thymic Carcinoma) 08/2009
1	Neoplasms (Cancer) 08/2009
1	Thymus Hyperplasia 08/2009
1	Necrosis 04/2007

Drug/Important Bio-Agent (IBA)

7	Natalizumab (Tysabri)FDA Link 09/2022 - 08/2014
7	Alemtuzumab (Campath)FDA Link 01/2022 - 02/2016
6	Messenger RNA (mRNA)IBA 01/2023 - 09/2010
6	Interferon-betaIBA 01/2017 - 07/2004
5	COVID-19 VaccinesIBA 11/2023 - 01/2022
5	InterferonsIBA 01/2016 - 07/2004
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2023 - 10/2019
3	VaccinesIBA 01/2023 - 05/2022
3	ocrelizumabIBA 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2014
3	CytokinesIBA 02/2016 - 09/2010
2	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 08/2009
2	Estrogens (Estrogen)FDA Link 10/2019 - 01/2018
2	Monoclonal AntibodiesIBA 08/2017 - 04/2017
2	Type A Botulinum Toxins (Botox)FDA Link 11/2016 - 12/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2023
1	Methylprednisolone FDA LinkGeneric 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	Air Pollutants (Pollutants, Air)IBA 12/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2022
1	nitazoxanide (NTZ)FDA Link 09/2022
1	CD52 AntigenIBA 01/2022
1	AntigensIBA 10/2021
1	Dimethyl FumarateIBA 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Progestins (Progestagens)IBA 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 11/2016
1	Interferon beta-1a FDA Link 02/2016
1	incobotulinumtoxinA FDA Link 12/2015
1	Therapeutic UsesIBA 12/2015
1	Interleukin-22 (IL-22)IBA 12/2014
1	Histone Deacetylase InhibitorsIBA 10/2014
1	AlbuminsIBA 09/2014
1	CreatinineIBA 09/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2012
1	ChemokinesIBA 09/2010
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2009
1	Interferon beta-1b (Betaseron)FDA Link 09/2008
1	Matrix Metalloproteinases (MMPs)IBA 04/2007
1	Immunoglobulin G (IgG)IBA 04/2007
1	InterleukinsIBA 04/2007
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2007

Therapy/Procedure

16	Therapeutics 11/2023 - 07/2004
3	Injections 11/2016 - 12/2015
1	Mediterranean Diet 03/2024
1	Continuity of Patient Care 12/2021
1	Secondary Prevention 03/2021
1	Analgesia 01/2019
1	Thymectomy 08/2009
1	Drug Tapering 07/2004